CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 3 of 16

Arthritis & Rheumatology

Briefs 81–120 of 607 CurrentRheuma has covered from this journal, newest publication first

Latest from Arthritis & Rheumatology

All coverage, newest first

  1. Arthritis Rheumatol

    Identifying Systemic Lupus Erythematosus From Serum Proteomic Profiles Using Machine Learning and Genetic Risk Stratification

    Diagnostic or prognostic studyLupus & APS

  2. Arthritis Rheumatol

    A Rare RIPK3 Variant Enhances Necroptosis and Promotes Inflammation in a Still Disease–Like Autoinflammatory Syndrome

    Mechanistic studyAutoinflammatory & rare

  3. Arthritis Rheumatol

    ANK1 and EPB41 Variants and The Risk of Glucocorticoid‐Induced Osteonecrosis

    Case-control studyLupus & APS

  4. Arthritis Rheumatol

    Lung Ultrasound for the Detection of Radiologic Progression of Interstitial Lung Abnormalities in Patients With Rheumatoid Arthritis

    Cohort studyRA

  5. Arthritis Rheumatol

    The Potential Role of Synovial T Cell Infiltration Following Knee Joint Injury in Symptoms and Progression to Osteoarthritis

    Mechanistic studyOsteoarthritis

  6. Arthritis Rheumatol

    Kidney Hematopoietic Stem and Progenitor Cells Contribute to Myeloid Development and Pathology in Lupus Nephritis

    Mechanistic studyLupus & APS

  7. Arthritis Rheumatol

    Interleukin‐2 Deprived State of Regulatory T cells and Their Recovery by Low‐Dose Interleukin‐2 in Patients With Inflammatory Myopathies

    Mechanistic studyMyositis

  8. Arthritis Rheumatol

    Determinants of Difficult‐to‐Manage and Treatment‐Refractory Axial Spondyloarthritis: A Cross‐Sectional Analysis Within a Longitudinal Cohort

    Cross-sectional studySpondyloarthritis & PsA

  9. Arthritis Rheumatol

    Differences in SARS ‐ CoV ‐2 Antigen Persistence in Individuals With Systemic Autoimmune Rheumatic Diseases Compared to the General Population: A RECOVER ‐Adult Cohort Study

    Cohort studyAcross diseases

  10. Arthritis Rheumatol

    Glucagon‐Like Peptide‐1 Receptor Agonist Therapy Is Associated With Improvement in Psoriatic Arthritis–Related and Metabolic Outcomes: A Retrospective Analysis of Two Cohorts

    Cohort studySpondyloarthritis & PsA

  11. Arthritis Rheumatol

    Higher Complement C4 Gene Copy Number Constitutes a Shared Genetic Risk Factor for Giant Cell Arteritis and IgA Vasculitis

    Case-control studyVasculitis & PMR

  12. Arthritis Rheumatol

    Per‐ and Polyfluoroalkyl Substances and Knee Osteoarthritis: Data From the Osteoarthritis Initiative

    Cohort studyOsteoarthritis

  13. Arthritis Rheumatol

    Association of Epigenetic Trajectory With Development of Clinical Rheumatoid Arthritis in Individuals With Anti–Citrullinated Protein Antibody Positivity: Targeting Immune Responses for Prevention of Rheumatoid Arthritis ( TIP ‐ RA )

    Cohort studyRA

  14. Arthritis Rheumatol

    Functional Impact of Structural Damage in Psoriatic Arthritis: Insights from a Prospective Cohort Study

    Cohort studySpondyloarthritis & PsA

  15. Arthritis Rheumatol

    Identification of Novel Noncoding Genetic Variants of Serum Urate Using Whole‐Genome Sequencing in 7,339 Chinese Participants

    Research articleGout & crystals

  16. Arthritis Rheumatol

    Immune Complexes Shape the Pathogenicity of Autoantibodies in Systemic Autoimmune Diseases: Insights From an FcγRIIIA ‐Reporter Assay

    Cross-sectional studyAcross diseases

  17. Arthritis Rheumatol

    auto scoRA : Deep Learning to Automate Sharp/van der Heijde Scoring of Radiographic Damage in Rheumatoid Arthritis

    Diagnostic or prognostic studyRA

  18. Arthritis Rheumatol

    High‐Resolution Deep Learning Dixon Magnetic Resonance Imaging of the Sacroiliac Joints Is Noninferior to Standard Magnetic Resonance Imaging in Patients With Suspected Axial Spondyloarthritis

    Diagnostic or prognostic studySpondyloarthritis & PsA

  19. Arthritis Rheumatol

    Biologic and Targeted Synthetic Disease‐Modifying Antirheumatic Drugs Do Not Arrest Bone Loss in Patients With Rheumatoid Arthritis: A Long‐Term Multicenter Observational Study

    Cohort studyOsteoporosis

  20. Arthritis Rheumatol

    TWEAK /Fn14 Signaling Drives Oxidative Cardiac Injury in Systemic Lupus Erythematosus: Evidence From Patient Biomarker Studies, Lupus Mouse Models, and Cardiomyocyte Assays

    Mechanistic studyLupus & APS

  21. Arthritis Rheumatol

    Single‐Cell Transcriptomic Analysis on Multi‐Subtypes of Idiopathic Inflammatory Myopathy Reveals Pathologic Hallmarks Associated With Stromal Stem and Immune Cells in Damaged Skeletal Muscles

    Mechanistic studyMyositis

  22. Arthritis Rheumatol

    Coverage Generosity of Novel Antirheumatic Drugs in Medicare Advantage and Stand‐Alone Part D Plans

    Cross-sectional studyRA

  23. Arthritis Rheumatol

    Integrative Multiomics Approaches Identify Biomarkers Associated With Progression From Arthralgia to Rheumatoid Arthritis

    Cohort studyRA

  24. Arthritis Rheumatol

    Multi‐Omic Profiling Reveals Immune Cell Priming Signature Linked to Lupus Prognosis

    Mechanistic studyLupus & APS

  25. Arthritis Rheumatol

    Single‐Cell Level Characterization of B Cell Depletion and Repopulation Following Rituximab in Systemic Lupus Erythematosus

    Mechanistic studyLupus & APS

  26. Arthritis Rheumatol

    Skin Transcriptomics Reveal Shared Molecular Mechanisms for Skin and Lung Involvement in Systemic Sclerosis

    Mechanistic studySystemic sclerosis

  27. Arthritis Rheumatol

    Unveiling Endotypes in Systemic Lupus Erythematosus Through Multiomic Analysis: Insights Into Cardiovascular and Renal Complications

    Cross-sectional studyLupus & APS

  28. Arthritis Rheumatol

    Validation of International Classification of Diseases Code–Based Case Definitions of Immune Checkpoint Inhibitor–Associated Inflammatory Arthritis From Administrative Health Data

    Diagnostic or prognostic studyAcross diseases

  29. Arthritis Rheumatol

    Autoantibodies to Joint‐Related Peptides Are Associated With Onset of Rheumatoid Arthritis in Presymptomatic Seronegative Individuals

    Diagnostic or prognostic studyRA

  30. Arthritis Rheumatol

    Baseline Interleukin‐10 Levels as a Predictive Biomarker for Achieving Clinical Response With Abatacept in Patients Who Were Disease‐Modifying Antirheumatic Drug Naive and Anti–Citrullinated Protein Antibody Positive With Early Rheumatoid Arthritis

    Secondary analysisRA

  31. Arthritis Rheumatol

    Association of Clonal Hematopoiesis With Incident, Late‐Onset, Seropositive Rheumatoid Arthritis

    Cohort studyRA

  32. Arthritis Rheumatol

    Efficacy and Safety of Guselkumab in Participants With Active Psoriatic Arthritis After Inadequate Response to One Prior Tumor Necrosis Factor Inhibitor: Week‐24 Results of a Phase 3, Randomized, Placebo‐Controlled Study

    Randomized controlled trialSpondyloarthritis & PsA

  33. Arthritis Rheumatol

    Behavioral Incentives for Exercise and Intra‐Articular Glucocorticoids for Knee Osteoarthritis: Results From a Factorially Designed Pragmatic Randomized Clinical Trial

    Randomized controlled trialOsteoarthritis

  34. Arthritis Rheumatol

    Landscape of Somatic Mutations in a Large Cohort of Chinese Patients With Immune Dysregulations

    Cross-sectional studyAutoinflammatory & rare

  35. Arthritis Rheumatol

    Inferring Rheumatoid Arthritis Disease Activity Status From the Electronic Health Records Across Health Systems

    Diagnostic or prognostic studyRA

  36. Arthritis Rheumatol

    PEPITEM Regulates the Synovial Microenvironment During Immune‐Mediated Inflammatory Arthritis to Limit Disease

    Mechanistic studyRA

  37. Arthritis Rheumatol

    Long Noncoding RNA H19 Mediates STAT3 ‐Dependent Activation of Keratinocytes and Fibroblasts in Systemic Sclerosis Skin

    Mechanistic studySystemic sclerosis

  38. Arthritis Rheumatol

    Effective Performance of the 2022 American College of Rheumatology/ EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in Pediatric Patients: An ARChiVe Study

    Diagnostic or prognostic studyPediatric

  39. Arthritis Rheumatol

    A Multifaceted Interplay Among Hemophagocytosis, Interleukin‐18, and Type I Interferon Distinguishes Still Disease From Other Autoinflammatory Diseases

    Mechanistic studyAutoinflammatory & rare

  40. Arthritis Rheumatol

    Subsets of Patients With Lupus Identified by Gene Expression Profiles Exhibit Differential Clinical Responsiveness to Baricitinib

    Secondary analysisLupus & APS

All 607 Briefs in ExploreShowing Briefs 81–120 of 607, newest first